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Abstract 
 
The aim of this study was to find the association between serum lipid ratios and 
insulin resistance among subjects with impaired glucose tolerance in Pakistan. It was 
also sought how effective was FBG to identify IGT subjects in context of using FBG 
as a screening tool for primary prevention.  
 
Research design and methods: 
Cross sectional analysis was conducted by utilizing the data from primary prevention 
project conducted within collaboration of Baqai Institute of Diabetology and 
Endocrinology (BIDE), Diabetic Association of Pakistan (DAP) and University of Oslo 
(UiO). Data analysis was divided into two section; the screening data, comprises of 
OGTT values of 1565 study participants after being short listed by using risk 
assessment form during the initial phase of project; and the baseline data, that 
constituted the anthropometric and biochemical variables of 242 subjects, included 
on basis of availability of all the required variables.  
 
Results: 
The prevalence of IFG, combined IFG-IGT and isolated IGT was found to be 10.9%, 
11.3% and 12.1% respectively. The specificity and sensitivity of fasting blood glucose 
to diagnose IGT was 48.6% and 82.6%, while the positive predictive value was 
50.7% and negative predictive value was found 81.1%. Data analysis at baseline 
showed no difference between mean ages and gender of combined IFG-IGT and 
isolated IGT group, however waist to hip ratio was significantly higher (p<0.05) in 
combined IFG-IGT group. Also, the levels of 2-hr blood glucose and serum 
triglycerides were higher in combined IFG-IGT group while fasting insulin levels were 
higher in isolated IGT group. All the lipid ratios (TC/HDL,TG/HDL and HDL/HDL) 
were found significantly correlated with fasting insulin levels and HOMA-IR in isolated 
IGT group. The AUC for TG/HDL ratio was 0.707 against the 75th percentile of 
fasting insulin level and HOMA-IR, while the cut off level >3.36 of TG/HDL ratio was 
found to have 65.5% sensitivity and 70% specificity with respect to the cut off of 
insulin resistance    
 
Conclusion: 
We have found significant correlation between serum lipid ratio and surrogate 
markers of insulin resistance in isolated IGT group. Due to the weak predictability of 
fasting blood glucose to diagnose IGT status, it is therefore suggested to use better 
option for the diagnosis of IGT in clinical practice. However, serum lipid ratios could 
be a potential option if used in conjunction with fasting blood glucose to identify 
subjects with isolated IGT who are found significantly more insulin resistant, and 
thus, can be more benefited by primary prevention of diabetes.      
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1.1. Country profile 
 
Pakistan is a federal state, comprises of four provinces: Punjab, Sindh, Khyber 
pakhtunkwa, and Balochistan as well as the federally administered tribal areas, Azad 
Jammu and Kashmir, and Islamabad as Capital of the country. In 2009, Gilgit 
Baltistan was assigned a province like status to establish self-government. The 
majority of southern Pakistan's population lives along the Indus River while Karachi is 
the most populous city in Pakistan.1 
 
 
Figure 1: Map of Islamic republic of Pakistan 
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1.1.1. People and demography 
 
The estimated population of Pakistan is over 187 million, and it is sixth most 
populous country in the world.2 The population of Pakistan is distributed over four 
provinces; three fourth of population lives in rural areas, and forty three million are 
living below poverty line.3 
Major ethnic groups constitute Punjabi, Sindhi, Baloch, Pathan and Mohajir (migrated 
from India at the time of division). Urdu is Pakistan’s national language and it is 
commonly understood through out communities and considered as main language of 
communication. The prominent local languages are Punjabi, Sindhi, Saraiki, Pashto, 
Balochi, Hingko, Brahui, and Brushaski. English and Urdu are official languages at 
federal and provincial government setup. Majority (42%) of the workforce is linked 
with agriculture sector, other workforce areas are Services (38%) and Industry (20%).    
 
During period of 1950 – 2011, the urban population of Pakistan increased by 
sevenfold whereas the increase in total population was fourfold. Currently the growth 
rate has been moderated to low i.e. 1.6% as compared to the previous high rate.4 
 
1.1.2. Geography 
 
The total area within the boundaries of Pakistan is 796,095 square kilometer. 
Gawader bay is the most southern part, and country extends northerly about 1,800 
kilometers to the Khunjarab Pass going to border of China. Pakistan is located in 
southern part of Asia, with Arabian Sea in the south, China in north, Afghanistan and 
Iran in west and India in the east.  The cost is 1,046 kilometers along Arabian Sea 
and land boundary is 6,774 kilometers with neighboring countries i.e. 909 kilometers 
with Iran, 2,430 kilometers with Afghanistan, 523 kilometers with China and 2,912 
kilometers with India. There are three main geographic regions in Pakistan; 
mountainous northern region that includes i.e. Hindu Kush, Karakoram and 
Himalayas, sparsely populated Baluchistan and Plains of Punjab and Sindh. River 
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Indus is main river extending from Kashmir, traversing Punjab and Sindh, and ends 
at the Arabian sea.5  
 
1.1.3. Economy 
 
The economy of Pakistan is mainly dependant  on agriculture sector while major bulk 
of export earning comes from textile industry. The transfer of money from overseas 
also contributes in establishing the economy. 
There was a period of strong economic growth especially during period between 
2003 to 2007. After 2007, the inflation has drastically affected the economy that was 
further deteriorated by 2010 floods. The disaster of 2010 flood affected all provinces 
and caused more then 43 billion US $ damage to economy.6  
Pakistan is provided with substantial natural resources like natural gas, coal, copper, 
iron, limestone, and salt. The major crops of Pakistan are wheat, rice, sugarcane, 
and cotton and fruits. In 2009, the GDP growth rate was 2.7% However, due to 
unequal distribution of resources and wealth, about one fifth of population has to 
survive on less then US $ 1.25 per day.7 
In 2011, the GDP (Gross Domestic Product) in Pakistan worth 211.09 billion US 
dollars.8  
 
1.1.4. Education 
 
The population with age more then 10 years has the literacy rate of 58.5%. Males 
has got higher literacy rate then females i.e. 70.2%  and 46.3% respectively.9 The 
rate of literacy also varies by region and especially by gender e.g. the literacy rate is 
3% in tribal areas.10 
The government initiated a nation wide program in 1998 to counter illiteracy and to 
provide basic education to all children.11 And it is expected that primary education will 
get 100% enrolment in year 2015 as ministry of education has applied various 
educational reforms for eradicating the illiteracy in the country.12  
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Table 1: Education infrastructure in Pakistan: 12 
Education Centers Total number 
Primary Schools 155,000 
Middle Schools 28,728 
High Schools 16,100 
Secondary Vocational Institutions 636 
Arts & Science Colleges 1,066 
Professional Colleges 382 
Universities 51 
 
 
1.1.5. Health profile 
 
Provincial government regulates health matters; responsible for delivery and 
management of health services. However, federal government (Ministry of Health) 
decides about health policy, research, training, and seeking foreign assistance. The 
core of health system constitutes the Basic Health units (BHUs) and Rural Health 
centers (RHUs). The secondary care includes inpatient care facilities, provided 
through Tehsil headquarters’ Hospitals (THQs) and District Health Quarter Hospitals 
(DHQs). Tertiary care via teaching hospitals is restricted to big cities of the country. 
Health sector in Pakistan got financing through taxation and out-of-pocket payments, 
however some minor contribution comes from donors. The social security schemes 
gives cover to only 3.5% employees, and 3.4% of population get support from Zakat 
and bait-ul-mal funds. In short, a comprehensive mechanism of social protection has 
not been developed.13 
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Table 2: Health infrastructure in Pakistan12 
 
Hospitals  916 
Dispensaries  4,600 
Basic Health Units (BHUs)  5,301 
Maternity & Child Health Centres   906 
Rural Health Centres (RHCs)  552 
Hospital Beds  99,908   
Doctors (registered)  113,206   
Dentists (registered)  6,127   
Nurses (registered)  48,446 
Paramedics  23,559 
Lady Health Workers  6,741 
 
 
 
1.1.6. Non-communicable diseases 
 
Non- Communicable diseases are one of the major causes of mortality and morbidity 
among Pakistani adults and inflict a substantial economic burden on families, 
societies and health system.14 NCDs and injuries are among the top ten causes of 
morbidity and mortality in Pakistan, and they account for approximately 54.9% of total 
deaths.15  
 
Usually, the workforce is the primary population that bears the burden of NCDs. In 
Pakistan, the current  population-based morbidity data on NCDs showed that one in 
three adults above the age of 45 years is suffering from high blood pressure.16 
In Pakistan, the diabetes is prevalent at the rate of 10%, whereas 40% men and 
12.5% women use tobacco by chewing or smoking. Karachi has the highest 
incidence of breast cancer among Asian population. Moreover, the country bears the 
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burden of estimated one million severely mentally ill individuals, and 1.4 million road 
traffic accidents accounted for 7000 fatalities.17  
Dealing with NCDs in Pakistan is a multidimensional challenge and requires 
appropriate investments and policies to be incorporated in development of health 
sector.18  
 
1.2. Background 
 
1.2.1. Diabetes mellitus 
 
Diabetes mellitus is a metabolic disorder of various etiologies characterized by 
hyperglycemia due to insulin resistance  and relative insulin deficiency.19  
However, in other type of diabetes the pathology may differ e.g. in type 1 diabetes 
there is absolute deficiency of insulin due to autoimmune or idiopathic destruction of 
beta cell in pancreas. Type 2 diabetes constitutes 90% of cases with diabetes while 
remaining are primarily due to type 1 and gestational diabetes.20 
1.2.2. Global prevalence of diabetes 
 
Up till 2011, there were 366 million people on the globe who had developed diabetes and it is 
estimated that 556 million will have diabetes in 2030.27 This scenario creates a serious 
concern regarding the capabilities of these states to cope with economical burden they might 
face in future.  
 
Table 3: Prevalence of diabetes and estimated diabetes numbers by region among adults age 20-70 
years for the years 2011 – 2030.27  
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Throughout Asia, the proportion of people with diabetes and obesity has increased, 
and there are no sign of slowing down in the increasing rate. The most populous 
countries of the world are located here, and there have been major changes has 
occurred in demographic, socio-economic, and epidemiological status in recent 
decade. Additionally, the under estimation of the economic burden associated with 
type 2 diabetes in Asian region has contributed the delay in suitable prevention and 
management plans by national and regional government authorities.22  
 
In major south Asian countries, the prevalence of diabetes has increased drastically 
due to urbanization. For example in Bangladesh, the prevalence of diabetes in rural 
areas increase from 2.3% to the level of 6.8% in less then a decade.23 
 
In Pakistan, the prevalence of diabetes ranges from 7.6 to 11%.24,25,26  
 
1.2.3. Economic burden of diabetes 
 
Globally, the prevalence of non communicable diseases is increasing remarkably. 
The deaths due to cardiovascular diseases have reached 18 million per year mainly 
contributed by diabetes and hypertension. The main culprit in this up rise of diabetes 
and hypertension is being identified as obesity. During the past decade, the 
developing world is threatened by joint venture of diabetes, hypertension, 
malnutrition and infectious diseases.28  
Increasing Prevalence of diabetes in developing countries, leading to increased 
morbidity and mortality.29 Due to improvement in socio-economic conditions the 
lifestyle has changed and causing significant increase in population with obesity and 
diabetes.  
 
1.2.4. Primary prevention of diabetes 
 
Diabetes is preventable, however once developed, it becomes more difficult to 
prevent the progression and complication of the disease. Primary prevention of 
diabetes is under focus since last few decades and has given promising results, while 
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several approaches have been identified to achieve these positive outcomes. South 
Asian countries, constituting India, Pakistan, Bangladesh, Sri Lanka and Nepal, have 
emerged as the prime host for the epidemic of diabetes. This scenario has developed 
within a relatively short period of two to three decades.30 
 
For primary prevention trial, the risk score assessment of subjects to be screened 
has found cost effective.31,32 The screening benefits among south Asians would be 
high because a large population with undiagnosed diabetes and intermediate 
hyperglycemia lives here, and therefore a cost effective approach can be well 
anticipated by both the government and people.  
In Pakistan, a primary prevention program33 was conducted during the period of 2006 
to 2009. Since December, 2011, a three year diabetes prevention program (PDPP) is 
under way in Karachi. This program was launched by Agha Khan University in 
collaboration by international Diabetes Federation and Helsinki University.   
 
1.2.5. Diagnosis of diabetes 
 
After every few years, the diabetes research communities reassess the current 
classifications, screening and diagnosis of diabetes, based on new research and 
clinical practices. 
In 1997, the American Diabetes Association issued diagnostic criteria for diabetes, 
followed by update in 2003 and 2010.34,35 Currently, the diagnosis of diabetes is 
based on one of the four abnormalities: fasting blood glucose, random elevated 
glucose with symptoms, abnormal oral glucose tolerance test (OGTT), or hemoglobin 
A1C (HbA1C). The patients having impaired fasting glucose (IFG) and/or impaired 
glucose tolerance are considered as high risk individuals who can develop diabetes 
more often then normal individuals.    
According to current ADA criteria, the diagnostic cut off for normal glucose tolerance, 
impaired fasting glucose, impaired glucose tolerance and diabetes are as 
follows:36,37,38  
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Normal — Fasting blood glucose (FBG) <100 mg/dL (5.6 mmol/L). Two-hour glucose 
during OGTT <140 mg/dL (7.8 mmol/L). 
Categories of increased risk for diabetes 
 Impaired fasting glucose (IFG) — FBG ≥100 to 125 mg/dL (5.6 to 6.9 
mmol/L) 
 Impaired glucose tolerance (IGT) — 2-h BG (75 g OGTT) ≥140 to 199 
mg/dL (7.8 to 11.0 mmol/L) 
 A1C — 5.7 to 6.4 percent (the International Expert Committee 
recommended 6.0 to 6.4 percent)  
Diabetes mellitus —FBG ≥126 mg/dL (7.0 mmol/L), 2-h BG ≥200 mg/dL (11.1 
mmol/L); random BG >200 mg/dL (11.1 mmol/L) in the presence of symptoms; A1C 
≥6.5 percent  
In absence of obvious symptoms of hyperglycemia, the diagnosis of diabetes must 
be confirmed by performing the same test on next day.   
 
1.2.6. Screening of diabetes in developing countries 
 
It is estimated that approximately 50% of all people with diabetes are not yet 
diagnosed. The diabetes that is undiagnosed found to be associated with higher risk 
of death. The Diabetes Epidemiology Collaborative Analysis of Diagnostic Criteria in 
Europe (DECODE) study, that was conducted on approximately 25000 people for a 
mean follow up period of 7.3 years showed that the hazard ratio for death was twice 
for subjects with type 2 diabetes as compared to normal subjects diagnosed through 
case detection program. A similar,  DECODA study conducted on Asian people 
reported similar trends.39  
 
In context of Asian countries, a major barrier towards population based screening of 
intermediate hyperglycemia is the expensive and time consuming OGTT.40 
Questionnaire based risk assessment of diabetes has been identified as an effective 
tool in European countries but such tools has not been validated in the developing 
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countries. The majority of people affected by IGT are living in middle or low income 
countries.41 Also the overall literacy level in developing countries may counter the 
effectiveness of such program.    
 
American diabetes association (ADA) has recommended fasting blood glucose as the 
preferred test for diagnosing diabetes and prediabetes, the reason for this 
recommendation is based on ease of use, lower cost and acceptability  to patients.42 
 
Also for clinical settings, the ADA expert penal has recommended the use of fasting 
blood glucose levels by doctors to screen their patients for diabetes because of ease 
and cost-effectiveness.43  
The fasting blood glucose values can easily be obtained at primary health care 
centers during routine visits and it can be performed with other test e.g. lipid profile 
that require  a fasting blood sample. And because of the simplicity of getting the 
fasting blood glucose levels, it is expected that a greater number of diabetes cases 
who are not diagnosed can easily be detected in routine clinical settings as if 
compared with OGTT.44  
In health system perspective, screening is cost effective when compared to no-
screening,45 and this cost effectiveness seems apparent that if we are considering 
the FBG as a screening tool due to its lower cost. However, the low sensitivity of FBG 
testing may lead to high false negative results and can therefore indirectly influence 
the overall estimation of economic burden related to the management of prediabetes. 
On the other hand, OGTT has been widely accepted as gold standard for screening 
and diagnosis of diabetes, however the cost and the time duration required are the 
major drawback while performing the population-based screening of pre diabetes.  
 
1.2.7. Intermediate hyperglycemia 
 
Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) are the 
intermediate states between normal glucose hemostasis and diabetes. The abnormal 
glucose regulation associated with IFG and IGT is represented by blood glucose level 
cut offs at fasting (8-12 hour) and at 2 hours after meals. By definition, IFG is defined 
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as elevated plasma blood glucose level between 100 to 126 mg/dl, and impaired 
glucose tolerance (IGT) is defined as the 2- hour blood glucose ≥140 and <200 mg/dl 
after 75 gram oral glucose load.46  
The mostly recommended sequence of testing for the diagnosis of diabetes is 
performing FBG first, and if found positive then on subsequent day followed by OGTT 
test to demonstrate presence of combined IFG/IGT.47  
When IFG was defined in 1997 by ADA as a means of classification of individuals 
having FBG between normal and diabetes, it was taken as analogous to IGT.48 
However, in 2003 the original FPG range (110 – 125) was modified to 100-125 mg/dl 
in order to make IFG testing more close to IGT test in identifying the population risk 
of developing diabetes. Consequently, the change in cut off point increased the 
prevalence of IFG by three to four folds in population.47  
The estimation of HbA1c has been included in the diagnostic criteria for diabetes 
since 2010 as recommended by ADA.  In a systematic review49 it was found, while 
referring to community and hospital based studies that the equivalent cut off points of 
HbA1c and FBG showed generally lower sensitivity in detecting IGT. In summary, 
HbA1c was found to have lower sensitivity but higher specificity than FBG to detect 
diabetes, however none of the two was found effective in detection of IGT. It was also 
interesting to note that both HbA1c and FPG do not include a glucose challenge. 
For FBG to diagnose IGT, it’s necessary for the person to be IFG first  i.e. combined 
IFG-IGT, and therefore the complete inability of FBG to detect isolated IGT is 
obvious.  
 
1.2.8. Insulin resistance 
 
Insulin resistance can be defined as inability of a known quantity of endogenous or 
exogenous insulin to induce insulin action (glucose uptake and utilization) in an 
individual as much as it does in a normal person. Insulin action is defined as the 
consequences after binding of insulin with its plasma membrane receptor followed by 
a series of protein-protein interaction. Occurrence of insulin resistance is a part of 
cardio-metabolic abnormalities commonly referred as “Insulin resistance syndrome” 
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or “Metabolic syndrome”, and may lead to type 2 diabetes, atherosclerosis, 
hypertension or polycystic ovarian syndrome depends upon the individual’s genetic 
background.50  
 
1.2.9. Insulin resistance and intermediate hyperglycemia 
 
Abnormalities in insulin action and insulin secretion are the major defects that are 
responsible for deterioration and progression of normal glucose tolerance to impaired 
glucose tolerance. It has been concluded by several prospective studies that insulin 
secretory dysfunction and insulin resistance predicts the transition of IGT to type 2 
diabetes in different populations51 A study that was carried out among Pima Indians 
(native American Indians) has shown that in subjects with normal glucose tolerance, 
a low insulin secretory response (initial phase of insulin secretion) to an intravenous 
dose of glucose is an independent and additional tool to predict development of 
diabetes.52 The first phase of insulin secretion is the immediate release of pre-formed 
insulin from beta cells of pancreas in response to glucose load. The body tries to 
compensate the decrease in first phase insulin secretion by increase in insulin 
production leading to hyperinsulinemic state. This hyperinsulinemic state declines as 
the disease progress along with decay of pancreatic beta cells leading to overt 
diabetes. 
The complications associated with IGT are mediated by glucotoxicity i.e. in excess, 
glucose directly damages protein, lipids and other molecules by non-enzymatic 
glycation. Glycation is a process of bonding of glucose with lipids or protein 
molecules. The accumulated advanced glycation end-products mediate the disease 
process by inhibiting the specific enzymatic function leading to micro vascular and 
macro vascular complications53 
There is a distinction exist between IGT and IFG with relation to insulin resistance. 
Several clinical studies have suggested that location of insulin resistance is different 
for these two disorders. The individuals with IGT have higher muscle insulin 
resistance along with mild hepatic insulin resistance, whereas the individuals with 
IFG have severe hepatic insulin resistance but their muscle insulin sensitivity is either 
normal or mildly deranged. The subjects with IGT also have abnormal or deficient 
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late-phase insulin secretion,54 that is manifested by post prandial or after-meal 
hyperglycemia. 
 
1.2.10. Insulin resistance and lipid abnormalities 
 
Dyslipidemias and hyperinsulinemia are the distinctive findings in individuals with 
insulin resistance, and these derangements have been recognized as increasing risk 
for cardio metabolic disorders.55 These Dyslipidemias show distinct pattern of altered 
lipid metabolism, particularly elevated plasma triglyceride and decreased HDL-
cholesterol concentrations and the presence of small, dense LDL particles.  The high 
triglyceride level in blood is associated with insulin resistance and obesity, and that is 
secondary due to high plasma insulin levels leading to increased esterification of fatty 
acids in liver resulting in formation of triglycerides. The low HDL level in blood is due 
to the increased catabolism of HDL molecules augmented by insulin resistance and 
hypertriglycedemic states.56 
In obesity, the increase in size of adipose tissues result in increased flow of free fatty 
acids (FFA) to other tissue, and that is responsible for increase in triglyceride content 
of these tissues. This condition leads to development of insulin resistance 
accompanied by other adverse effects and referred as lipotoxicity. Also, due to the 
higher FFAs in blood followed by expansion in adipose tissues, there is impairment in 
ability of insulin to suppress hepatic glucose output. These higher FFAs in blood 
contribute in decreasing the uptake of glucose by skeletal muscles. The increased 
triglyceride content of muscles correlates directly with insulin resistance, while the 
FFAs content of muscle phospholipids correlates inversely with insulin sensitivity in 
skeletal muscles.57 
 
1.2.11. Serum lipid ratios as a marker of insulin resistance 
 
The higher levels of LDL are atherogenic,58 however high HDL levels in blood have 
found to be cardioprotective.59 Higher concentration of TGs is also considered a risk 
factor for cardiovascular diseases. In addition to that, several studies are agreed 
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upon the utility of lipid ratios and found that TC/HDL and LDL/HDL are better 
predictor of cardiovascular diseases  then individual lipid marker.60,61,62 A study has 
shown negative correlation between TC/HDL and insulin-mediated glucose disposal 
highlighting the utility of these ratios in determining the insulin resistance.63  
Applicability of TG/HDL in identify insulin resistance in Aboriginals, Chinese, 
Europeans and immigrant South Asians was explored and found that the TG/HDL 
ratio may be a good marker to identify insulin-resistance.64  
In similar studies,65,66,67 the close association has been reported between triglyceride 
to high-density lipoprotein cholesterol ratio (TG/HDL) and insulin resistance, and it 
has been recommended to use TG/HDL as the surrogates for insulin resistance. 
In a study,65 published in 2013, a strong association has been observed between 
TG/HDL ratio and insulin resistance in youths, and it was suggested that TG/HDL 
ratio can be a strong candidate for a surrogate of insulin resistance and 
atherosclerosis in young population. 
 
1.3. Rationale of the study 
 
The association of lipid ratios with insulin resistance among native south Asians has 
not been studied. The identification of insulin resistance by the routine estimation of 
fasting lipid profile and lipid ratios could be a way towards early identification of 
people at risk. 
The link between insulin resistance and IGT has been established, however, in 
developing countries, clinicians may have subjected to use fasting blood glucose to 
diagnose diabetes as it is convenient and cost effective. But what if fasting blood 
glucose is found negative, it would be difficult to convince the person being tested 
that although he/she is normal but there might be a possibility of having isolated 
impaired glucose tolerance. Most likely the person who got negative result of fasting 
blood glucose may be asked to come after one year to check his/her blood sugar. 
And, therefore the population with isolated IGT would be ignored. 
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Fasting insulin levels and HOMA-IR has been identified has a surrogate for insulin 
resistance, but the cost and the acceptability of measuring insulin resistance via 
fasting insulin levels in routine clinical consultation needs to be considered. The 
laboratory cost for estimation of fasting insulin levels is three times higher then lipid 
profile test, and the acceptance and understanding of serum lipid measurement in 
general public is relatively high. Additional, in a resource restricted country e.g. 
Pakistan, it would be worthwhile to investigate the utility of serum lipid ratios for 
identification of insulin resistance 
The purpose of this study is to find the predictability of FBG to diagnose IGT in our 
study population, and explore the association between serum lipid ratios and insulin 
resistance markers in IGT subjects.  
 
1.4. Objective of the study 
 
1.4.1. General objective 
 
The major aim of study was to find the association between lipid ratios and 
insulin resistance in subjects with impaired glucose tolerance in Pakistan 
 
1.4.2. Specific objective 
 
1- To examine the predictability of fasting blood glucose testing to identify 
impaired glucose tolerance (IGT) status in Pakistani population. 
2- To compare and find the association between insulin resistance and lipid 
ratios in I-IGT and combined IGT-IFG group  
3- To explore the associated factors that can assist in early detection of impaired 
glucose tolerance.  
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1.4.3. Research question 
 
i. Is there any association between ratios of lipid profile components with 
insulin resistance and/or glycemic status among Pakistani subjects? 
ii. Is fasting blood glucose test sufficient to demarcate normal glucose 
tolerance from impaired glucose tolerance? 
iii. Can we suggest serum lipid ratios for screening of insulin resistant or  
impaired glucose tolerance status? 
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CHAPTER 2: METHODOLOGY 
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2.1. Research setting 
 
Karachi: The data comprises of anthropometric and biochemical information of 
subjects living in Karachi. It is the largest city of Pakistan, fourth most populated city 
in the world69 and also the capital city of the province of Sindh. Karachi is said to be 
the main industrial and trade center of the country, situated in southern end of 
Pakistan, it is the main sea-port dealing major bulk of import and export. Karachi is 
also called as mini-Pakistan due to several ethnic groups living here. Metropolitan of 
Karachi is divided in 5 districts; Karachi south, Karachi east, Karachi central, Karachi 
west, and Malir.70  
 
2.2. Study population 
  
The study population comprised of Subjects from the primary prevention project that 
was conducted during period from 2006 to 2009 in Karachi and represents all the 
ethnic groups  
 
2.3. Research design 
 
This was a cross sectional study designed to explore the difference between sub-
groups of intermediate hyperglycemia among Pakistani population 
 
2.4. Criteria for inclusion 
 
Inclusion of data at screening level was based on high risk identification for diabetes 
through questionnaire with following characteristics: 
 
1. Age greater then 30 years 
2. No known diabetes 
3. At least one family member with diabetes 
4. Absence of serious physical and metal disabilities 
5. Willing to join the study 
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The data of all subjects with OGTT test, fasting lipid profile and fasting insulin levels 
was included in the study. Impaired glucose tolerance is described as blood glucose 
levels of ≥140 to <200 mg per decilitre after twelve hour fasting with subsequent oral 
intake of 75 gram Glucose (Glaxose-D or dextrose). Testing was revised in subjects 
with abnormal results and the mean of the two tests was used to include subjects in 
the study.  
 
2.5. Exclusion criteria 
 
Non availability of required variables 
 
2.6. Outcome assessment 
The outcome of interest was prevalence of intermediate hyperglycemia in subgroups, 
association between lipid profile components, insulin levels, anthropometric 
measurements, fasting blood glucose and 2-hr blood glucose 
 
2.7. Data collection 
Data was taken from collaborative project of Baqai Institute of Diabetology & 
Endocrinology (BIDE), Diabetic Association of Pakistan (DAP), and University of Oslo 
(UiO). This project was aimed towards primary prevention of diabetes and extended 
over the period from 2006 to 2009. The data was collected from the project at 
screening level that constitutes the subjects with varying degree of glucose tolerance 
i.e. extending from normal glucose tolerance to diabetes based on OGTT test, and at 
baseline level that included anthropometric measurements and laboratory 
investigations. 
The data was received as forms stored in lock and key designated for the project and 
located at Baqai Institute of Diabetology and Endocrinology (BIDE). The data 
information was then transformed into SPSS document for statistical analysis.   
For the primary prevention project, around 1825 suspected high risk individuals 
identified through the ‘high risk questionnaire’ and from these identified high risk 
subjects 1739 underwent oral glucose tolerance test. The test was found positive for 
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747 individuals including IFG, combined IFG-IGT, I-IGT and diabetes. After excluding 
the normal and diabetic individuals, the data of 242 subjects was available for 
analysis with laboratory investigations (fasting blood glucose, 2-hour OGTT blood 
glucose, fasting lipid profile and fasting insulin levels). 
2.8. Statistical analysis 
 
All statistical analyses were performed using IBM SPSS Statistics 20 software. Data 
are presented as means with standard deviation. The data was checked for 
normality. Comparisons of means between sub-groups of intermediate 
hyperglycemia (combined IFG-IGT and isolated IGT) were performed with one-way 
ANOVA. Linear correlations were estimated with Pearson correlations. Receiver 
operator curve characteristics were calculated while using the 75th percentile values 
of fasting insulin levels and HOMA-IR.  
 
2.9. Variables 
 
Anthropometric variables: 
Age (years) 
Gender 
Body mass index  
Waist to hip ratio 
Systolic blood pressure (mm. Hg) 
Diastolic blood pressure (mm. Hg) 
 
Biochemical variables: 
Fasting blood glucose (mg/dl) 
2-hour blood glucose (mg/dl) 
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Total cholesterol (mg/dl) 
Triglycerides (mg/dl) 
High density lipoproteins (mg/dl) 
Low density lipoproteins (mg/dl) 
Fasting serum insulin levels (mg/dl) 
TG/HDL ratio 
TC/HDL ratio 
LDL/HDL ratio 
HOMA-IR 
Age is defined as years, and the age of subjects included in the project was greater 
then 30 years.  Anthropometric measurements included weight (Kg), height (cm), 
waist (cm) and hip circumference (cm). During the measurements the participants 
were asked to wear light clothing and take off their shoes. Height was measured to 
the nearest cm and weight to the nearest 0.1 kg. Standardized scale was used for 
measurement of weight and standardized stick was used for measuring height. Waist 
circumference was measured as central point between the iliac crest and lower 
margin of rib at mid axillary line. 
Plasma glucose was measured by using the standard glucose oxidase-peroxide 
method while the lipid profile was estimated by standard enzymatic procedure. 
Fasting insulin levels was measured and used for calculating the insulin resistance by 
using fasting blood glucose  
 
2.10. Sample size calculation 
 
The minimum sample size calculated by using the following formula; 
 
    
    n        =         Z2 pq 
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                              d2 
 
Where 
n = sample size 
z = 1.96 at 95% confidence 
Prevalence of impaired glucose tolerance = 15% 
p= 0.15 
q=1-p = 0.85 
d = 0.05 maximum allowable error 
n      =      (1.96)2 x 0.15 x 0.85 
                      (0.05)2 
n     =          196 
 
 
Total estimated sample size was 196. 
 
 
2.11. Defining insulin resistance 
 
There is not much consensus on defining the optimal cut off for insulin resistance. 
McAuley et al.71 concluded that fasting insulin > 12 mU/l in normoglycemic subjects is 
a remarkable specific test for insulin resistance. While Laassko72 has found that 
fasting insulin levels >18 mU/l as the indicator of insulin resistance in normal 
population. Both studies used euglycemic clamp (gold standard), however broad 
variation in cut off values was explained by difference in ethnicity.  
Although considered as gold standard, euglycemic clamp technique may not be 
feasible in epidemiological studies due to cost and sophistication of the procedure.73 
Fasting insulin level is considered best available proxy to identify insulin resistance, 
however other simple measures are being sought because there are different 
methods of assaying insulin and therefore it is not possible to suggest a single 
universal cut-off. Insulin resistance could be defined as the 75th percentile of the 
fasting insulin level in non-diabetic population under study.74 Similarly, insulin 
resistance can also be defined by 75th percentile of HOMA-IR in subjects without 
diabetes.75 However in a study,76 the 75th percentile of HOMA-IR has been used to 
define the cut off of insulin resistance in subjects with diabetes while concluding the 
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optimal cut offs for diagnosis of metabolic syndrome according to IDF and ATP-III 
criteria. 
 
In a recent study77 the insulin resistance has been defined by using the euglycemic 
clamp (gold standard), concluding that insulin resistance can be estimated with good 
sensitivity and specificity (89% and 65% respectively) from HOMA-IR values 
2.8<HOMA-IR>5.8 with HDL values being less then 51mg/dl. 
 
In our study, the 75th percentile of fasting insulin level and HOMA-IR is being used 
considering our study population being non-diabetic.   
 
2.12. Ethical clearance 
 
The study protocol has been approved by the regional Norwegian Ethics Committee. 
The primary prevention project from where data was collected had approval from 
institutional review board of the Baqai Institute of Diabetology and Endocrinology 
(BIDE), and Norwegian research council. 
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CHAPTER 3: RESULTS 
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Results are described in two separate sections. In first section, the screening data 
(N=1565) of the primary prevention project was analyzed considering two variables 
i.e. fasting blood glucose and 2-hour OGTT blood glucose. Afterwards, the sensitivity 
and specificity of fasting blood glucose with respect to oral glucose tolerance (OGTT) 
was estimated by cross tabulation. 
In second section the baseline data of primary prevention project was analyzed 
(N=242), limited by the availability of required variables. The data was split into two 
groups i.e. subjects having both impaired fasting glucose and impaired glucose 
tolerance (combined IFG-IGT) and isolated impaired glucose tolerance (I-IGT), these 
groups were compared on the basis of mean differences and correlation. Afterwards, 
the Receiver operating characteristics (ROCs) were calculated for lipid ratios.  
3.1. Analysis of screening data  
 
 
Figure 2: The distribution/frequency of glycemic status among the screened population 
 
52.2% 
13.2% 
12,1% 
10,9% 
11.3% 
Distribution of glycemic status 
among screened population (N = 
1565) 
Normal 
Diabetes 
I-IGT 
IFG 
IFG-IGT 
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Figure 2 shows the distribution of glycemic status among the screened subjects. 
There were 818 (52.2%) subjects with normal glucose tolerance. The prevalence of 
prediabetes status as defined by the sub-groups i.e. IFG, combined IFG-IGT and I-
IGT was 10.9%, 11.3% and 12.1% respectively. The diabetes was found to be 13.2% 
among the screened population. 
 
 
Figure 3: The distribution of intermediate hyperglycemia (prediabetes) in screened population  
 
In figure 3, the percentages of prediabetes subgroups are shown. There were total 
539 subjects found to have prediabetes and among them IFG, I-IGT, and combined 
IFG-IGT were 172 (31.9%), 190 (35.2%) and 177 (32.8) respectively. 
 
 
 
 
 
35.2% 
31.9% 
32.8% 
Proportions of abnormal glucose 
hemostasis among subjects with 
either IFG, IGT or IFG-IGT (N= 539) 
I-IGT 
IFG 
IFG-IGT 
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 IGT based on 2-hour blood glucose 
IFG Positive Negative  
Positive 177 (IGT-IFG) 172 (IFG) 349 
Negative 190 (I-IGT) 818 (NGT) 1008 
Total 367 990 1357* 
                     *Excluding 208 diabetes cases 
 
 
 
 
 
 
 
 
Sensitivity 48.2 % 
95% CI: 43.0 % to 
53.4 %  
Specificity 82.6 % 
95% CI: 80.1 % to 
84.9 %  
Positive Predictive 
 Value 
50.7 %  
95% CI: 45.3 % to 
56.0 % 
Negative Predictive 
Value 
81.1 %  
95% CI: 78.6 % to 
83.5 % 
 
Table 4 shows the cross tabulation between fasting blood glucose with respect to 
OGTT in total 1357 subjects. The diabetes positive (208) cases were not included in 
the calculation. There were 177 true positive, 818 true negative, 172 false positive 
and 190 were false negative results. In table 5, the sensitivity and specificity of 
fasting blood glucose level was found to be 48.6% (95% CI: 43.5-53.8) and 82.6% 
(95% CI: 80.1-84.9) respectively. At the same time, the positive predictive value was 
50.7% and negative predictive value was 81.1%.   
Table 5: The sensitivity and specificity of fasting blood glucose levels (cut off 
point ≥ 100 to < 126) to diagnose the impaired glucose tolerance (cut off 
point ≥ 140 to < 200) based on oral glucose tolerance test (OGTT) 
 
Table 4: Cross tabulation between Fasting blood glucose levels (cut off 
points: ≥100 - ≤126) and2-hour OGTT (≥140 - ≤200). 
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3.2. Analysis of baseline data 
 
3.2.1. General characteristics and comparison of groups 
 
Table 6: General characteristics & comparison of means  between combined IFG-IGT and I-IGT group 
 
Variables 
Combined 
IFG-IGT 
Mean ± SD 
I-IGT 
Mean ± SD 
Total 
Mean ± SD 
p-value 
N 120 122 242 - 
* Gender (Male/Female) 85/35 83/39 168/74 0.370 
Age (years) 43.9±10.2 43.4±9.9 43.7±10.1 0.674 
Body mass index (kg/m2) 26.6±5.1 27.4±4.65 27.0±4.8 0.258 
Waist to hip ratio 0.89±0.09 0.87±0.08 0.88±0.09 0.028 
Systolic blood pressure (mm 
Hg)  
120.8±14.1 119.7±17.20 120,2±15,8 0.621 
Diastolic blood pressure 
(mm Hg) 
83.1 ±12.1 83.8 ± 9.92 83.5 ± 11.0 0.602 
* Categorical variable is expressed in number 
 p < 0.05 considered statistically significant 
 
 
 
Table 6 shows the general characteristics of the subjects categorized by impaired 
glucose tolerance subgroups i.e. combined IFG-IGT and I-IGT, comprised of 168 
man and 74 women with no significant difference(p>0.05) in gender ratio. The mean 
age of the subjects in combined IFG-IGT group was 43.9 ±10.2, and 43.4±9.9 in I-
IGT group with no significant difference observed (p>0.05). Also, there were no 
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intergroup differences in Body mass index, Systolic blood pressure and diastolic 
blood pressure, however the waist to hip ratio was significantly higher in combined 
IFG-IGT group as compared to I-IGT group.   
 
 
Table 7: Biochemical characteristics and comparison of mean between combined IFG-IGT and I-IGT group 
 
Variables 
Combined 
IFG +IGT 
Mean ± SD 
I-IGT 
Mean ± SD 
Total 
Mean ± SD 
p-value 
N 120 122 242 - 
OGTT-2 hrs blood sugar 
(mg/dl) 
162.0 ± 17.75 152.5±16.3 158.7±17.3 0.003 
Total Cholesterol (mg/dl) 181.8± 32.1 175.3±35.4 178.5±33.9 0.138 
Triglyceride (mg/dl) 169.0±122.92 138.5±70.0 153.6±100.7 0.018 
HDL (mg/dl) 37.9±6.3 38.2±4.6 38.1±5.5 0.679 
LDL (mg/dl) 118.8±22.7 114.8±23.8 116.8±23.3 0.182 
Fasting insulin levels (mµ/liter) 9.39±5.06 11.44±5.8 10.42±5.55 0.004 
 
* p < 0.05 considered statistically significant 
 
 
The biochemical characteristics of two groups (combined IFG-IGT and I-IGT) are 
shown in table 7. The mean 2-hour blood glucose (162.8±17.75) was significantly 
higher in combined IFG-IGT group as compared to mean 2-hour blood glucose 
(152.5±16.3) in I-IGT group. The lipid levels i.e. total cholesterol, high density 
lipoproteins, and low-density lipoproteins, however showed no significant difference 
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among the groups except the triglycerides levels that were significantly higher 
(169.0±122.9) in combined IFG-IGT group when comparing the I-IGT group 
(138.5±70.0). The mean fasting insulin level was also found significantly higher 
(11.44±5.8) in I-IGT group as compared to combined IFG-IGT group (9.39±5.06).  
 
3.2.2. Correlations 
 
Table 8: Correlation of blood glucose levels with fasting insulin levels in combined IFG-IGT and I-IGT group
   
Variables 
Combined IFG-IGT I-IGT 
r p-value r p-value 
Fasting blood glucose -0.313 0.001 0.214 0.020 
2-hour blood glucose -0.192 0.038 -0.032 0.730 
p < 0.05 considered statistically significant 
                 
 
Table 8 shows the correlation between blood glucose levels with fasting insulin 
levels. In combined IFG-IGT subjects there was highly significant negative correlation 
(r=-0.313, p = 0.001)) was found between fasting blood glucose and fasting insulin 
levels. There was also significant correlation exist between fasting blood glucose and 
fasting insulin levels in I-IGT group but the correlation was found to be positive (r 
=0.214, p=0.020). The 2-hour blood glucose in combined IFG-IGT group also 
showed positive correlation with fasting insulin levels, however there was no 
significance found among I-IGT subjects. 
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Table 9: Correlation of serum lipids with fasting insulin levels among 
Combined IFG-IGT and I-IGT group 
   
Variables 
Combined IFG-IGT I-IGT 
r p-value r p-value 
TC -0.275 0.003 0.133 0.153 
TG -0.169 0.071 0.254 0.006 
LDL -0.250 0.007 0.136 0.145 
HDL -0.131 0.164 -0.240 0.009 
 
p < 0.05 considered statistically significant 
TC = Total cholesterol                   
TG = Tryglycerides 
LDL = Low density lipoproteins 
HDL = High density lipoproteins 
                    
 
 
 
The association between individual serum lipid levels with fasting insulin levels is 
shown in table 9. In combined IFG-IGT group, the total cholesterol (TC) and low-
density lipoproteins (LDL) found negatively correlated(r= - 0.275 and r= -0.250) with 
fasting insulin level, however the triglycerides (TG) and high-density lipoproteins 
(HDL) showed no significant association among this group. Inversely, in I-IGT group, 
the TG and HDL showed significant correlation (p=0.006 and p=0.009) with fasting 
insulin levels, however, the TC and LDL did not show significant correlation with the 
fasting insulin levels.  
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Table 10: Correlation of serum lipids with HOMA-IR among combined IFG-IGT and I-IGT group 
   
Variables 
Combined IFG-IGT I-IGT 
r p-value r p-value 
TC -0.269 0.004 0.125 0.177 
TG -0.169 0.072 0.214 0.020 
LDL -0.249 0.007 0.126 0.172 
HDL 0.076 0.418 -0.236 0.010 
 
*p < 0.05 considered statistically significant 
TC = Total cholesterol                   
TG = Triglycerides 
LDL = Low density lipoproteins 
HDL = High density lipoproteins 
 
 
 
 
In table 10, the correlation analysis is shown between surrogate of insulin resistance 
i.e HOMA-IR and the individual lipid profile component in combined IFG-IGT and I-
IGT group.  The TC and LDL were found negatively correlated (r = - 0.269 and r = - 
0.249) with fasting insulin levels in combined IFG-IGT subjects, while TG and HDL 
showed no significant correlation in this group. Meanwhile the I-IGT group showed 
opposite results i.e. TG and HDL showed significant correlation with fasting insulin, 
however the correlation with TC and LDL was found insignificant.   
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Table 11: Correlation of lipid ratios with fasting insulin levels among combined IFG-IGT and I-IGT group 
   
Variables 
Combined IFG-IGT I-IGT 
r p-value r p-value 
TC/HDL -0.142 0.129 0.282 0.011 
TG/HDL -0.133 0.155 0.359 0.001 
LDL/HDL -0.133 0.158 0.321 0.003 
 
*p < 0.05 considered statistically significant 
TC = Total cholesterol                   
TG = Triglycerides 
LDL = Low density lipoproteins 
HDL = High density lipoproteins 
 
 
 
All the lipid ratios (TC/HDL, TG/HDL and LDL/HDL) showed no significant correlation 
(P>0.05) with the fasting insulin levels in combined IFG-IGT group, however all the 
lipid ratios (TC/HDL, TG/HDL and LDL/HDL)  were found significantly correlated with 
fasting insulin level in I-IGT group (Table 11). 
 
 
Table 12: Correlation of lipid ratios with HOMA-IR 
   
Variables 
Combined IFG-IGT I-IGT 
r p-value r p-value 
TC/HDL -0.140 0.134 0.272 0.014 
TG/HDL -0.135 0.150 0.339 0.002 
LDL/HDL -0.134 0.152 0.312 0.005 
 
*p < 0.05 considered statistically significant 
 r = pearson’s correlation 
TC = Total cholesterol                   
TG = Triglycerides 
LDL = Low density lipoproteins 
HDL = High density lipoproteins 
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In table 12, the correlation of HOMA-IR with lipid ratios is shown. Although 
insignificant (p>0.05), all the lipid ratios ((TC/HDL, TG/HDL and LDL/HDL) showed 
negative correlation with HOMA-IR. While in I-IGT group, all the lipid ratios i.e 
TC/HDL, TG/HDL and LDL/HDL were found to have significant positive correlation 
(p>0.005) with the HOMA-IR index. 
 
3.2.3. Receiver operating characteristics (ROC) analysis 
 
Following section is related to the ROC analysis of lipid ratios (TG/HDL, TC/HDL and 
LDL/HDL) against the 75th percentile of the fasting insulin levels and HOMA-IR index. 
The 75th percentile of both the fasting insulin levels and HOMA-IR were used as cut 
off for insulin resistance in our study group and found to be 16.45 µunit/liter and 3.8 
respectively. 
 
Triglyceride/High density lipoprotein ratio (TG/HDL): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) (a) 
Figure 4: ROC curve of TG/HDL ratio with 75
th
 percentile of 
fasting insulin level  
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Figure 4  and 5 shows the ROC curve for the TG/HDL ratio with the 75th percentile of 
fasting insulin level (16.45) and HOMA-IR (3.8). The Area Under the Curve (AUC) for 
TG/HDL was found to be 0.707 and 0.697 for fasting insulin level and HOMA-IR 
respectively. 
 
Total cholesterol/High density lipoprotein ratio (TC/HDL) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: ROC curve of TC/HDL ratio (a) with 75
th
 percentile of fasting insulin level  
 
Figure 5: ROC curve of TG/HDL ratio with 75
th
 percentile of 
HOMA-IR.  
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In figure 6, the ROC curve for TC/HDL ratio with 75th percentile of fasting insulin 
levels (16.45) is shown, having AUC of 0.688. The figure 7 shows the ROC curve 
plotted between TC/HDL and the HOMA-IR cut-off and AUC was found to be 0.668.      
 
Total cholesterol/High density lipoprotein ratio (LDL/HDL): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: ROC curve of TC/HDL ratio with 75
th
 percentile of 
HOMA-IR .  
 
Figure 8: ROC curve of LDL/HDL ratio (a) with 75
th
 percentile 
of fasting insulin level  
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The ROC curves of LDL/HDL ratio with insulin resistance cut offs is shown in figure 8 
and 9. The AUC between LDL/HDL and 75th percentile of fasting insulin levels 
(16.45) was  0.690 and the AUC with 75th percentile of HOMA-IR (3.8) was found to 
be 0.670. 
3.2.4. Sensitivity and specificity of lipid ratio with insulin resistance cut-off 
 
The area under the ROC curve (AUC) is a summary statistic of diagnostic 
performance. The AUC could distinguish between non-predictive (AUC< 0.5), less 
predictive (0.5<AUC>0.7), moderately predictive (0.7<AUC>0.9), and highly 
predictive (0.9<AUC>1).The AUC of > 0.7 is considered moderately predictive and 
we have found AUC of 0.707 with TG/HDL ratio plotted against 75th percentile of 
fasting insulin level. Therefore, the sensitivity and specificity is measured and 
presented in table 10 with various cut offs of TG/HDL ratios.  
Figure 9: ROC curve of LDL/HDL ratio with 75
th
 percentile of 
HOMA-IR.  
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Table 13: Lipid ratio (TG/HDL) values and their sensitivity & specificity 
with respect to 75th percentile fasting insulin level cutoff (16.45) 
 
Lipid ratio 
(TG/HDL) 
Sensitivity Specificity 
>1,6931 100% 
6.8% 
>2,2589 93.1% 
20.5% 
>2,3929 89.7% 
30.7% 
>2.6587 82.8% 
42.0% 
>2.8073 72.4% 
46.6% 
>2.9184 69.0% 
50.0% 
>3,0262 66.5% 
56.8% 
>3.3598 66.5% 
70.0% 
>3.7697 65.5% 
78.4% 
>4.0125 51.7% 
80.7% 
>4.8083 41.4% 
88.6% 
>5.1808 31.0% 
89.8% 
>6.6627 17.2% 
94.3% 
>8.7623 10.3% 
96.9% 
>11.3074 3.4% 
100% 
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CHAPTER 4: DISCUSSION 
  
  
        50 
 
Syed Maqsood Mohiuddin  
 
The main objective of the study was to find the association between serum lipid ratios 
and insulin resistance surrogates. In our study we have found that all the lipid ratios 
(TC/HDL, TG/HDL, and LDL/HDL) in isolated IGT group were significantly associated 
with fasting insulin levels and HOMA-IR. In combined IFG-IGT group, however, there 
was no association observed between serm lipid ratios and insulin resistance. The 
presence of association between lipid ratios and insulin resistance in one subgroup 
of IGT signifies the importance of segregating and studying the I-IGT and combined 
IFG-IGT group separately. Clinically, it will help in targeting the insulin resistant 
population, a preferred domain for primary prevention of diabetes.  
 
4.1. Methodological discussion 
 
Cross sectional study may encounter a number of problems which may invalidate the 
results unless addressed properly. This methodology section has focused on 
objectives, however questions on strength and weaknesses of the study can be 
raised. 
 
4.1.1. Strength of the study 
 
4.1.1.1. Sample size 
 
A large sample size was available for analysis that was otherwise difficult to obtain 
during the period for M Phil data collection. The greater the number of samples the 
higher would be the chances to find differences in mean. In first section of data 
analysis a sample size of 1565 subjects were available to generalize the results on 
the specific population with enough statistical power and avoiding the random error. 
4.1.1.2. Cost and time 
 
While doing the cross sectional data analysis, the prevalence of subgroups of 
intermediate hyperglycemia has been estimated by utilizing the current available 
data, that has minimized the cost and time. The prevalence of Isolated IGT has been 
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estimated first time in Pakistani population. Additionally, the associations were 
examined between anthropometric and biochemical variables within the same 
framework to extend the diversity of the study. 
 
4.1.1.3. Experimentation 
 
The cross sectional data analysis provides opportunity to accommodate new 
development in field of research, and therefore, redefining the categories and 
exploring the new objectives becomes possible. In our study, we are able to analyze 
the pre defined IGT group into two sub-groups i.e. Combined IFG-IGT and isolated 
IGT, and this segregation has provided the (could be) new explanation of insulin 
resistance and beta cell failure in these sub-groups.  
 
4.1.2. Weaknesses of the study 
4.1.2.1. Selection bias 
 
Selection bias occurs when certain charachterstics of the subject influence the 
inclusion, and consequently might also effect the outcome. The selection bias is 
mediated by inability to  randomize, and if not accounted for or acknowledge, then 
the validity of the study is compromised. By using a random selection procedure we 
can control the selection bias by providing everyone the equal chance to be selected. 
Statistically, all observational studies have builtin bias but the challenge is to interpret 
how selection bias can effect the outcome of the research.  
The two potential sources of selection bias has been identified for this study; the 
selection of samples during the initial phase of the primary prevention project, and 
during the acquisition and analysis of data for the current study. To identify the 
selection bias inharited with the parent project, it was sought how the randomization 
was done. The selection of subjects was based on OGTT results, this had made the 
selection specific to the high risk subjects. It was assured that all the subjects had 
similar baseline charachterstics by stratification according to age. The measurement 
bias was addressed by using stuctured questionnaire, and availability of trained staff 
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to conduct measurement. For the current study, the data was acquired from the 
written forms and the inclusion of samples was based on the availabilty of all the 
variables required for the data analysis, thus 242 samples were available to perfrom 
the statistical analysis.    
4.1.2.2. Confounding 
 
When a part or entire variable is influenced by another variable, the issue is termed 
as confounding. It was addressed in parent project while doing the stratification by  
age during randomization. Majority of the data was collected from work force, while in 
Pakistan, the majority of the women are house bound. This may have limit the 
availability of large number of subjects who are relatively less active. However, the 
representation of gender, age and BMI  in groups were similar to minimize the 
confounding effect.    
4.1.2.3. External validity for generalization 
 
External validity for generalization is assured when results of a study can be 
generalized to other situations and to other people in a population. In our study the 
samples were gathered from Karachi which have proportions of all the major ethnic  
groups of Pakistan, and efforts were made that sample would represent the general 
population. The selected high risk population based on IGT is comparable to the 
same high risk population in pakistan.   
 
4.1.2.4. Cause and effect relationship 
Although we have found significant association between the lipid ratios, fasting 
insulin levels and HOMA-IR, the inability of cross sectional data analysis to define 
cause and effect differentiation has limit the significance of the study.   
 
4.1.2.5. Limited variables 
A very specific weakness related to the study is unavailability of IFG (subgroup of 
intermediate hyperglycemia) to explain the results more precisely. Although, studies 
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are available that has analyzed the three subgroups of intermediate hyperglycemic (I-
IFG, combined IFG-IGT, I-IGT) providing the reason for analyzing two groups, the 
completeness of analysis can be questioned. However, this weakness can provide 
basis for future study addressing all subgroups. 
 
4.1.2.6. Weaknesses related to primary prevention project 
Accumulations of weaknesses related to the primary prevention project are inherited 
and unadjustable i.e. related to the methodology (survey techniques, anthropometric 
& biochemical measurements, and selection biases). 
 
4.2. Discussion on findings 
 
4.2.1. Prevalence of sub-groups of intermediate hyperglycemia 
 
In Pakistan, the studies done on intermediate hyperglycemia has followed the 
definition of IGT consisting of both I-IGT and combined IFG-IGT, this could have led 
the non availability of any study comparing I-IGT and combined IFG-IGT group in 
Pakistani population. In this study, we have found the opportunity to find out the 
prevalence of isolated IGT first time in study population.  
The overall prevalence of intermediate hyperglycemia in our study population was 
36.3%, constituting the I-IFG, combined IFG-IGT and I-IGT in proportion of 10.9%, 
13.2% and 12.1% respectively. The relatively higher prevalence of intermediate 
hyperglycemia in our study as compared to previous studies81,82,83,84 conducted in 
four phases in four provinces by National diabetes survey of Pakistan, and in another 
study by Hydrie et al.85 is probably due to the selection of high risk subjects (family 
history of diabetes and age > 30 years).   
The importance of segregating the intermediate hyperglycemia into the respective 
subgroups has provided opportunity to examine the differences in anthropometric 
and biochemical parameters. A similar study being done recently in Bangladesh86 
showed the prevalence of  I-IFG, combined IFG/IGT and I-IGT being 1.3%, 2.3% and 
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2.3%. Again, the low prevalence of intermediate hyperglycemia as compared to our 
study is most probably due to the selection of general rural population irrespective of 
risk factors, also the lower age limit (>20 years) may have to be considered as a 
cause of relatively low prevalence.  
4.2.2. Predictability of fasting blood glucose  to diagnose impaired glucose tolerance 
 
In our study, the fasting blood glucose level (cut off point ≥ 100 to < 126) was found 
to have sensitivity of 48.2% to identify IGT subjects in study population. In a similar 
study78 that was conducted to evaluate the diagnostic predictability of fasting blood 
glucose cut off with respect to OGTT (gold standard), it was found that if fasting blood 
glucose cut-off would have been used alone, 81% of subjects with isolated IGT would 
be diagnosed as having normal glucose tolerance. A similar study79 has concluded 
that screening for diabetes using fasting glucose levels had very low sensitivity as 
compared to OGTT. 
The low sensitivity of FBG  in detecting IGT signifies the importance of exploring 
differences among the subgroups of intermediate hyperglycemia. According to the 
existing classification, impaired glucose tolerance comprises both isolated and 
combined IFG-IGT group, the further subdivision of IGT has been explored in our 
study to identify differences among the subgroups. As suggested by a study80 the 
isolated IGT and combined IFG-IGT follow different pathways towards development 
of diabetes, same pattern is seem in our study population.   
 
4.2.3. Differences between combined IFG-IGT and Isolated IGT group  
 
There were significant differences found between the combined IFG-IGT group and I-
IGT group, these difference were observed in waist to hip ratio, OGTT 2 hour blood 
glucose, triglycerides and fasting insulin levels. According to a five year follow-up 
study conducted  in Danish population i.e. inter9980 it was concluded that IFG, 
isolated IGT and combined IFG-IGT are distinct pre-diabetes status and follow a 
different pathway towards development of diabetes. In the same study it was 
demonstrated that early compensatory increase in beta-cell function may be initiated 
by higher elevated fasting plasma glucose (IFG and combined IFG-IGT) but not by 2 
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hour plasma blood glucose level. It was also observed that the characteristics of 
combined IFG-IGT subjects are more in common with IFG subjects as compared to I-
IGT subjects. It was therefore suggested that the subjects with isolated high 2-hour 
blood glucose should be titled as different entity from combined IFG-IGT as it is 
currently suggested by World Health Organization.     
No gender and age difference among the group were found and hence provided the 
lesser confounding owning to these variables. The BMI wasn’t differ between the 
group and i.e. already high according to the classification of current normal BMI in 
Asian population. 
 
The difference in anthropometric measurement among the groups included waist to 
hip ratio that was found significantly higher in the combined IFG-IGT group, the 
biochemical parameters i.e. 2-hr blood glucose and triglycerides were also 
significantly higher in the combined IFG-IGT group. Higher waist to hip ratio, 2 hr 
blood glucose and triglycerides represents the more deteriorated metabolic status 
among combined IFG-IGT group, however the significantly higher insulin levels in I-
IGT group represents a distinct feature representing the presence of insulin 
resistance in this group.  
 
Several studies87,88,89 has examined the ADA defined IGT90 as separate IFG-IGT and 
I-IGT groups. This subdivision in our study has led to some important findings related 
to the associated markers of insulin resistance and beta-cell failure.    
 
4.2.4. Correlation of fasting insulin levels with blood glucose levels 
 
This section includes the discussion on correlations between insulin resistance 
markers (fasting insulin levels and HOMA-IR) and variables in both I-IGT and 
combined IFG-IGT group. Perhaps the most interesting finding is the presence of 
significant positive correlation of fasting insulin levels with fasting blood glucose in I-
IGT group, and significant negative correlation of fasting insulin levels with fasting 
blood glucose in combined IFG-IGT group. It has been established in various 
studies71,72,91 that insulin resistance is characterized by the high insulin levels, and at 
the same time the progression of intermediate hyperglycemia is represented by 
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higher blood glucose levels. Therefore, the reciprocity exist between fasting insulin 
levels and fasting blood glucose in combined IFG-IGT group indicates that 
progression/worsening of  combined IFG-IGT status is associated with beta cell 
failure i.e. characterized by decline in fasting insulin levels. Where as in I-IGT group, 
there is significant positive correlation is found between fasting insulin levels and 
fasting blood glucose, indicating the increment in insulin levels with 
progression/worsening of I-IGT status. It is therefore suggested that the basic 
pathophysiological mechanism behind progression/worsening of I-IGT status is 
insulin resistance.  
The association between fasting insulin levels and 2-hour blood glucose was 
significant in combined IFG-IGT group, however no significance between these two 
was observed in I-IGT group. While describing the association between fasting 
insulin levels and 2-hour blood glucose, it is important to notify that glycemic 
response needs to be assessed by insulin levels at that particular instance i.e. at 2-
hr, and in our study, only the fasting insulin levels were available. Therefore, the 
associations between fasting insulin levels and 2-hour blood glucose could not be 
explained on the basis of current result.  
 
4.2.5. Correlation between insulin resistance surrogates with serum lipids 
 
We have examined the association between serum lipids and their ratios with fasting 
insulin levels and HOMA-IR. The derangement in serum lipids is one of the 
characteristics of intermediate hyperglycemia,92 and our results are consistent with 
this observation. In examining the association, we have found interesting results i.e. 
in combined IFG-IGT group, the serum total cholesterol and LDL were negatively 
associated with fasting insulin levels, probably due to the declining insulin levels 
associated with beta cell failure,93 however, the HDL and TG showed no association 
with fasting insulin levels in combined IFG-IGT group. The association of HDL and 
TG with insulin resistance has been found independently in several studies94,95,96 and 
absence of such association (in our study) confining to the combined IFG-IGT group 
may have indicate that insulin resistance is not a characteristic of this group. 
However, the significant association of fasting insulin levels with TC and LDL may 
have indicated that intermediate hyperglycemia as single entity is generally 
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associated with dyslipidemias, but more precise explanation is needed to describe 
the finding. 
The I-IGT group has shown association of fasting insulin levels with serum TG and 
HDL, probably indicating the peculiar pattern (high TG low HDL) of dyslipidemia in 
this group. As mentioned earlier, the high TG and low HDL are characteristic of 
insulin resistance, this finding has further added the assumption that insulin 
resistance could be the pathophysiological mechanism behind the development of I-
IGT, however as a rule, the causality could not be inferred on the basis of cross 
sectional analysis. 
4.2.6. Lipid ratios and insulin resistance 
 
An apparent distinction is observed between the two groups i.e.  significant positive 
correlation was found between all the lipid ratios (TC/HDL, TG/HDL, and LDL/HDL) 
and fasting insulin levels among I-IGT group and no significant observation was 
noted for combined IFG-IGT group. Similar results were observed while comparing 
the groups by using the HOMA-IR as surrogate for insulin resistance.  In a previous 
study97 conducted in Canada, that included four ethnicities including immigrant south 
Asians, has found lipid ratios to be associated with insulin resistance in all ethnicities 
except in immigrant south Asians. The reason could be the use of different BMI cut 
off for south Asians. Among all lipid parameters and ratios, the TG/HDL ratios has 
consistently been under consideration due to better association with insulin 
resistance.68,98,99 Similarly, In our study, TG/HDL ratios had the highest correlation 
with fasting insulin level and HOMA-IR (r = 0.359, and r = 0.339) in I-IGT group. 
However, the insignificant but negative correlation with IR surrogates in combined 
IFG-IGT group is showing same trends i.e. observed for individual lipid components 
and fasting blood glucose levels. 
 
4.2.7. Sensitivity and specificity of TG/HDL ratio with insulin resistance cut offs 
 
The sensitivity and specificity of serum lipid ratio has been estimated with the insulin 
resistance cut offs. Considering the AUC > 0.7 as moderately predictive, the TG/HDL 
ratio shown to have the reasonable specificity and sensitivity at various cut offs. With 
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the ratio of > 3.36, the TG/HDL ratio has shown the sensitivity and specificity of 
65.5% and 70% respectively. The observed value of TG/HDL ratio in our study is 
consistent with  McLaughlin and colleagues68 who have found that TG/HDL ratio ≥ 
3.5 has a moderate ability to predict insulin resistance (47% sensitivity, 88% 
specificity) in Caucasian population. However, in a similar study100 done on non 
Hispanic Caucasians and Mexican Americans, it was reported that the optimal cut off 
point of hyperinsulinemia (insulin resistance) was 3.0. The same study also reported 
that a single cut off point may not be applicable to a population with different ethnic 
groups. 
In a recently conducted study101 on patient with PCOs (polycystic ovarian disease) 
has found strong correlation between serum lipid ratios (TC/HDL, TG/HDL and 
LDL/HDL) and insulin resistance. PCO is a classical example of insulin resistant 
status, thus similar trends in our study, indicates potential utility of these ratios in I-
IGT group.    
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CHAPTER 5: CONCLUSION, 
RECOMMENDATIONS AND FUTURE 
RESEARCH IMPLICATION 
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5.1. Conclusion 
 
We have found significant correlation between serum lipid ratios (TC/HDL,TG/HDL 
and LDL/HDL) and surrogate markers of insulin resistance in isolated IGT group. The 
highest correlation was observed between TG/HDL and fasting insulin levels. The 
AUC for the various cut offs of TG/HDL ratio was measured against the 75th 
percentile of insulin resistance surrogates, and it was found that lipid ratios, 
specifically TG/HDL ratio can be proposed has a potential marker for insulin 
resistance in Pakistani population.  
The individual serum lipid component (TC,TG,LDL and HDL) and their ratios were 
found to have significant and opposite correlations with fasting insulin levels and 
HOMA-IR among IGT sub groups. Also, the significantly higher insulin levels in 
isolated IGT may have indicated that insulin resistance could be the characteristics of 
this group. The findings in our study may suggest that the IGT group as a whole can 
be sub divided into combined IFG-IGT group and isolated IGT group to explore the 
differences that may lead to the better understanding of pathophysiology of impaired 
glucose tolerance.   
Due to the weak predictability of fasting blood glucose to diagnose IGT status, it is 
therefore suggested to use better option for the diagnosis of IGT in clinical practice. 
However, serum lipid ratios could be a potential option if used in conjunction of 
fasting blood glucose to identify subjects with isolated IGT who are found significantly 
more insulin resistant, and thus, can be more benefited by primary prevention of 
diabetes.     
   
5.2. Recommendations 
 
- Diagnosis of intermediate hyperglycemia is of utmost importance in primary 
prevention of diabetes, and only the execution of such program if based on 
fasting blood glucose  can results in a high proportion of IGT individuals 
remaining undetected. The target population needs to be identified that can 
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better be benefited by the resource restricted intervention efforts in developing 
countries. 
- OGTT would be the best screening tool, however the other convenient and 
cost effective methods needs to be explored to extend the primary prevention 
efforts in clinical practices 
- Reliance on FBG on screening of diabetes in clinical practice needs to be 
reassessed. 
- Combined testing using fasting blood glucose and fasting lipid profile needs to 
be explored in context of screening for intermediate hyperglycemia.  
 
5.3. Future research implications 
 
- Further research is needed to explore the implication of FBG and lipid profile 
in identifying intermediate hyperglycemia. The overall acceptance of lipid 
profile testing in community could be helpful to validate the findings by 
involvement of a large number of populations. 
- Isolated IGT group can present the research ground for investigating the 
phenomenon of insulin resistance by more sophisticated methods i.e. 
euglycemic clamp in Pakistani population. 
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